Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Graphite Bio Inc (GRPH)

  • Technical Exchange News
  • March 22, 2024, 00:23 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Graphite Bio, Inc. - Common Stock. New value: Graphite Bio, Inc. - Common Stock.

Comment Full text

Graphite Bio Inc (GRPH)

  • Technical Exchange News
  • March 22, 2024, 00:23 UTC
  • 31
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Graphite Bio, Inc. - Common Stock.

Comment Full text

Graphite Bio Inc (GRPH)

  • Technical Exchange News
  • March 22, 2024, 00:23 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Graphite Bio, Inc. - Common Stock.

Comment Full text

Graphite Bio Inc (GRPH)

  • Technical Exchange News
  • March 22, 2024, 00:22 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Graphite Bio, Inc. - Common Stock. New value: Graphite Bio, Inc. - Common Stock.

Comment Full text

Graphite Bio Inc (GRPH)

  • Technical Exchange News
  • March 22, 2024, 00:22 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Graphite Bio, Inc. - Common Stock.

Comment Full text

Graphite Bio Inc (GRPH)

  • Technical Exchange News
  • March 22, 2024, 00:22 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Graphite Bio, Inc. - Common Stock.

Comment Full text

Virax Biolabs Group (VRAX)

  • Technical Exchange News
  • March 20, 2024, 21:10 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Mustang Bio Inc (MBIO)

  • Technical Exchange News
  • March 20, 2024, 21:09 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Virax Biolabs Group (VRAX)

  • Technical Exchange News
  • March 20, 2024, 21:03 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Aptevo Therapeutics Inc. (APVO)

  • Technical Exchange News
  • March 20, 2024, 21:02 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 744
  • 745
  • 746
  • 747
  • 748
  • Next

Search

News categories

  • Technical Exchange News(12023)
  • Event(5238)
  • SEC News(249559)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(149906)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin